Wave Life Sciences (WVE) stock: insider trades, news & valuation
Net buying
Close · Oct 9, 2026
$3.46
-0.3% on the day
-57.8% over 12 months
52-week range $3.46 – $21.31
Share price and insider trades
WVE closeInsider buyInsider sale
Bought, 12 months$82.6M
Sold, 12 months$16.2M
Insiders buying2
Insiders selling11
Wave Life Sciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $82.6M and 11 sold $16.2M of WVE stock on the open market.
Get emailed when insiders cluster-buy stocks like WVE
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
WVE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $135K | 4 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $54.6M | 4 | $908K | 8 |
| Q4 2025 | $27.9M | 2 | $15.1M | 35 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit−$47.1MOn all tracked purchases -57.1%
Summary
Over the past 12 months, 2 Wave Life Sciences, Inc. insiders reported open-market purchases totaling $82.6M, while 11 insiders reported sales totaling $16.2M. Among insiders with enough purchase history to measure, Ra Capital Management, L.P. (Director) has the highest Insider Score at 92. 43 of 47 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 13SEC | Adrian RawcliffeDirector | Sell Plan | 12,700 | $5.29 | $67K | -34.6% | — |
| Aug 13SEC | Heidi L WagnerDirector | Sell Plan | 7,00044,930 held (−13%) | $6.01 | $42K | -42.4% | — |
| Aug 13SEC | Ken TakanashiDirector | Sell Plan | 3,86420,079 held (−16%) | $6.01 | $23K | -42.4% | — |
| Aug 13SEC | Aik Na TanDirector | Sell Plan | 43224,968 held (−2%) | $6.01 | $3K | -42.4% | — |
| Mar 30SEC | Ra Capital Management, L.P.Director | Buy | 4,954,55823,157,567 held (+27%) | $6.06 | $30.0M | -42.9% | 92 |
| Mar 30SEC | Ra Capital Management, L.P.Director | Buy | 2,495,62326,004,414 held (+11%) | $6.43 | $16.0M | -46.2% | 92 |
| Mar 30SEC | Ra Capital Management, L.P.Director | Buy | 971,09126,975,505 held (+4%) | $6.50 | $6.3M | -46.8% | 92 |
| Mar 30SEC | Ra Capital Management, L.P.Director | Buy | 351,22423,508,791 held (+2%) | $6.38 | $2.2M | -45.8% | 92 |
| Feb 27SEC | Chris FrancisSee Remarks | Sell Plan | 17,90061,867 held (−22%) | $15.09 | $270K | -77.1% | — |
| Feb 27SEC | Chris FrancisSee Remarks | Sell Plan | 15,29461,867 held (−20%) | $15.00 | $229K | -76.9% | — |
| Feb 11SEC | Paul BolnoCEO, President | Sell | 10,480275,520 held (−4%) | $13.45 | $141K | -74.3% | — |
| Feb 11SEC | Kyle MoranCFO | Sell | 3,588134,385 held (−3%) | $13.45 | $48K | -74.3% | — |
| Feb 11SEC | Chandra VargeeseSee Remarks | Sell | 3,228408,246 held (−1%) | $13.45 | $43K | -74.3% | — |
| Feb 11SEC | Chris FrancisSee Remarks | Sell | 1,88361,867 held (−3%) | $13.45 | $25K | -74.3% | — |
| Jan 6SEC | Chris FrancisSee Remarks | Sell Plan | 8,08026,295 held (−24%) | $15.92 | $129K | -78.3% | — |
| Jan 6SEC | Chris FrancisSee Remarks | Sell Plan | 1,29525,000 held (−5%) | $16.70 | $22K | -79.3% | — |
| Dec 15SEC | Plc Gsk10% Owner | Buy | 1,470,00018,245,691 held (+9%) | $19.00 | $27.9M | -81.8% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 122,34925,000 held (−83%) | $14.20 | $1.7M | -75.6% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 107,40025,000 held (−81%) | $14.56 | $1.6M | -76.2% | — |
| Dec 10SEC | Kyle MoranCFO | Sell Plan | 50,00090,365 held (−36%) | $20.03 | $1.0M | -82.7% | — |
| Dec 10SEC | Kyle MoranCFO | Sell Plan | 50,00089,218 held (−36%) | $18.00 | $900K | -80.8% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 50,00025,000 held (−67%) | $16.00 | $800K | -78.4% | — |
| Dec 10SEC | Kyle MoranCFO | Sell Plan | 60,00089,218 held (−40%) | $13.20 | $792K | -73.8% | — |
| Dec 10SEC | Kyle MoranCFO | Sell Plan | 50,000139,218 held (−26%) | $15.00 | $750K | -76.9% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 45,88225,000 held (−65%) | $14.50 | $665K | -76.1% | — |
| Dec 10SEC | Kyle MoranCFO | Sell Plan | 50,00089,218 held (−36%) | $13.20 | $660K | -73.8% | — |
| Dec 10SEC | Adrian RawcliffeDirector | Sell Plan | 42,00012,700 held (−77%) | $15.00 | $630K | -76.9% | — |
| Dec 10SEC | Christian O HenryDirector | Sell Plan | 30,00012,700 held (−70%) | $18.02 | $541K | -80.8% | — |
| Dec 10SEC | Christian O HenryDirector | Sell Plan | 42,00012,700 held (−77%) | $12.75 | $536K | -72.9% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 37,50025,000 held (−60%) | $14.08 | $528K | -75.4% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 28,12525,000 held (−53%) | $14.50 | $408K | -76.1% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 25,00025,400 held (−50%) | $15.00 | $375K | -76.9% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 22,50025,000 held (−47%) | $14.08 | $317K | -75.4% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 17,90025,000 held (−42%) | $15.00 | $268K | -76.9% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 21,00025,400 held (−45%) | $12.75 | $268K | -72.9% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 21,00025,400 held (−45%) | $12.75 | $268K | -72.9% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 17,23025,400 held (−40%) | $15.00 | $258K | -76.9% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 20,00050,400 held (−28%) | $12.75 | $255K | -72.9% | — |
| Dec 10SEC | Christian O HenryDirector | Sell Plan | 15,00012,700 held (−54%) | $14.07 | $211K | -75.4% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 15,00042,630 held (−26%) | $12.75 | $191K | -72.9% | — |
| Dec 10SEC | Gregory L. VerdineDirector | Sell Plan | 12,020283,197 held (−4%) | $13.09 | $157K | -73.6% | — |
| Dec 10SEC | Chris FrancisSee Remarks | Sell Plan | 9,37525,000 held (−27%) | $15.00 | $141K | -76.9% | — |
| Dec 10SEC | Mark CorriganDirector | Sell Plan | 9,60035,330 held (−21%) | $13.09 | $126K | -73.6% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 7,49425,400 held (−23%) | $15.00 | $112K | -76.9% | — |
| Dec 10SEC | Gregory L. VerdineDirector | Sell Plan | 7,980275,217 held (−3%) | $14.05 | $112K | -75.4% | — |
| Dec 10SEC | Heidi L WagnerDirector | Sell Plan | 7,00044,930 held (−13%) | $14.00 | $98K | -75.3% | — |
| Dec 10SEC | Aik Na TanDirector | Sell Plan | 7,49432,894 held (−19%) | $12.75 | $96K | -72.9% | — |
| Dec 10SEC | Mark CorriganDirector | Sell Plan | 6,51528,815 held (−18%) | $14.07 | $92K | -75.4% | — |
| Dec 10SEC | Heidi L WagnerDirector | Sell Plan | 7,00044,930 held (−13%) | $13.00 | $91K | -73.4% | — |
| Dec 10SEC | Christian O HenryDirector | Sell Plan | 6,44512,700 held (−34%) | $12.75 | $82K | -72.9% | — |
| Dec 10SEC | Kyle MoranCFO | Sell Plan | 3689,218 held (−0%) | $20.25 | $729 | -82.9% | — |
| Nov 14SEC | Adrian RawcliffeDirector | Sell Plan | 16,11512,700 held (−56%) | $6.79 | $109K | -49.0% | — |
| Nov 14SEC | Ra Capital Management, L.P.Director | Buy | 1,00018,203,009 held (+0%) | $6.69 | $7K | -48.3% | 92 |
Insiders at Wave Life Sciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ra Capital Management, L.P.Director | $54.6M | — | Mar 30, 2026 | 92 |
| Plc Gsk10% Owner | $27.9M | — | Dec 15, 2025 | — |
| Chris FrancisSee Remarks | — | $7.1M | Feb 27, 2026 | — |
| Kyle MoranCFO | — | $4.2M | Feb 11, 2026 | — |
| Aik Na TanDirector | — | $1.8M | Aug 13, 2026 | — |
| Christian O HenryDirector | — | $1.4M | Dec 10, 2025 | — |
| Adrian RawcliffeDirector | — | $807K | Aug 13, 2026 | — |
| Gregory L. VerdineDirector | — | $269K | Dec 10, 2025 | — |
| Heidi L WagnerDirector | — | $231K | Aug 13, 2026 | — |
| Mark CorriganDirector | — | $217K | Dec 10, 2025 | — |
| Paul BolnoCEO, President | — | $141K | Feb 11, 2026 | — |
| Chandra VargeeseSee Remarks | — | $43K | Feb 11, 2026 | — |
| Ken TakanashiDirector | — | $23K | Aug 13, 2026 | — |
WVE stock: common questions
Are Wave Life Sciences, Inc. insiders buying WVE stock?
In the past 12 months, 2 insiders reported open-market purchases of WVE worth $82.6M. The latest was Director Ra Capital Management, L.P. bought $30.0M of WVE at $6.06 — largest purchase by this insider in our records; raises the stake by 27%.
Are Wave Life Sciences, Inc. insiders selling WVE stock?
11 insiders reported sales worth $16.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is WVE's 52-week range?
Over the past year WVE has traded between $3.46 and $21.31. It last closed at $3.46 on Oct 9, 2026.